Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...

However, a team of scientists at China’s Fudan University has recently built prototype retinal implants that can replace the ...

Can AI really replace scientists? Robin, an AI system, identified a potential drug for vision loss, but scientists are ...

oxidative stress and gene disruption in the retinal pigment epithelium (RPE), a vital layer of cells in the eye. These changes may explain why older adults are more vulnerable to age-related eye ...

FORT LEE, N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age ...

N.J.--(BUSINESS WIRE)--Luxa Biotechnology LLC (Luxa), a clinical-stage biotechnology company developing a novel adult retinal pigment epithelial stem cell (RPESC) therapy for dry age-related macular ...

human retinal organoids, stem cell-derived retinal pigment epithelial cells, human retinas, and human retinal pigment epithelial cells. This comprehensive approach provides very strong evidence ...

Human iPSCs forming a two-dimensional layer generate in vitro retinal pigment epithelial cells, which are pigmented and display typical cobblestone morphology. Hexagonal morphology and ...

Lad, MD, PhD, vice chair of ophthalmology clinical research at Duke Health, discusses a presentation at the ARVO meeting on retinal pigment epithelium cells in age-related macular degeneration.

RG6501 (OpRegen ®) is a suspension of human allogeneic RPE cells currently ... (i) OpRegen, a retinal pigment epithelial cell therapy in Phase 2a development for the treatment of geographic ...

The peer-reviewed, open-access research has been published in the journal Materials & Design ("Retinal pigment epithelial cells can be cultured on fluocinolone acetonide treated nanofibrous scaffold") ...